Cancer Biology and Advances in Treatment

2020
ISBN: 978-3-030-57256-3
Verlag: Springer International Publishing

Buch, Englisch, Band 1292, 174 Seiten, Paperback, Format (B × H): 178 mm x 254 mm, Gewicht: 366 g

Reihe: Innovations in Cancer Research and Regenerative Medicine

This new series, based on a bi-annual conference and its topics, represents a major contribution to the emerging science of cancer research and regenerative medicine. Each volume brings together some of the most pre-eminent scientists working on cancer biology, cancer treatment, cancer diagnosis, cancer prevention and regenerative medicine to share information on currently ongoing work which will help shape future therapies. These volumes are invaluable resources not only for already active researchers or clinicians but also for those entering these fields, plus those in industry. Cancer Biology and Advances in Treatment is a proceedings volume which reflects papers presented at the 3rd bi-annual Innovations in Regenerative Medicine and Cancer Research conference; taken with its companion volume Tissue Engineering and Regenerative Medicine and Stem Cells: Biology and Engineering it provides a complete overview of the papers from that meeting of international experts.

Zielgruppe

Research

Autoren/Hrsg.

Pham, Phuc Van

Fachgebiete

• Naturwissenschaften Biowissenschaften Zellbiologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung

Inhaltsverzeichnis

1. The BRCA1 and BRCA2 genes in early onset breast cancer patients.- 2. Anti-cancer effect of Xao tam phan Paramignya trimera methanol root extract on human breast cancer cell line MCF-7 in 3D model.- 3. A novel nonsense mutation c.374C>G in CYP21A2 gene of a Vietnamese patient with congenital adrenal hyperplasia.- 4. Variation of Mitochondrial DNA HV1 AND HV2 of the Vietnamese Population.- 5. Synthesis and Characterization of PLGA-PEG Thymoquinone Nanoparticles and its Cytotoxicity Effects in Tamoxifen-resistant Breast Cancer Cells.- 6. Adipose-derived mesenchymal stem cells promote growth and migration of lung adenocarcinoma cancer cells.- 7. Predictive potential of PD-L1, TYMS and DCC expressions in treatment outcome of colorectal carcinoma.- 8. Clinical trials with cytokine-induced killer cells and CAR-T cell transplantation for non-small cell lung cancer treatment.- 9. Isopanduratin A isolated from Boesenbergia pandurata reduces HepG2 hepatocellular carcinoma cell proliferation in both monolayer and three-dimensional cultures.- 10. Hopea Odorata extract can efficiently kill breast cancer cells and cancer stem like cells in three-dimensional culture more than in monolayer cell culture.- 11. Selective cytotoxicity of some plant extracts against hepatocellular carcinoma cells but not mesenchymal stem cells: A pilot screening.

Über Autor(innen)

Phuc Van Pham received his Ph.D. in Human Physiology from Vietnam National University, Ho Chi Minh City, Vietnam. He is currently a Professor of Biology at Vietnam National University and Director of the Stem Cell Institute. He is a longstanding lecturer and translational scientist at the University, and is a member of several societies and journal editorial boards focused on stem cells and cancer research.

Dr. Pham and his colleagues have established one of the first multidisciplinary stem cell centers in Vietnam, and he has successfully launched an array of technologies in stem cell technologies. His research interests include stem cell biology and therapy, immunotherapy and regenerative medicine and he has published extensively in these areas.

After many years of experience as an embryologist, cell biologist, and molecular biologist, collaborating with leading researchers in Singapore, Japan, and the United States, Dr. Pham is a student again, keen to reach beyond the traditional boundaries of biology.